Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
0.867
-0.007 (-0.76%)
At close: Apr 28, 2026, 4:00 PM EDT
0.836
-0.031 (-3.60%)
After-hours: Apr 28, 2026, 6:04 PM EDT
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $76.53 million as of April 28, 2026. Its market cap has increased by 72.75% in one year.
Market Cap
76.53M
Enterprise Value
73.61M
1-Year Change
72.75%
Ranking
Category
Stock Price
$0.87
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has decreased from $90.21M to $76.53M, a decrease of -15.17%. That is a compound annual growth rate of -4.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 77.11M | -9.07% |
| Dec 31, 2025 | 84.80M | 3.05% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alpha Teknova | 170.41M |
| Cardiol Therapeutics | 154.53M |
| Journey Medical | 140.75M |
| Assertio Holdings | 116.45M |
| SCYNEXIS | 81.03M |
| BGM Group | 61.26M |
| Cumberland Pharmaceuticals | 60.72M |
| Incannex Healthcare | 56.32M |